NVS - MorphoSys gains after gaining U.S. antitrust approval for sale to Novartis
2024-03-22 10:29:19 ET
More on MorphoSys
- MorphoSys AG (MOR) Q4 2023 Earnings Call Transcript
- Novartis And MorphoSys Are A Perfect Match
- MorphoSys: Positive Pelabresib Data Finally Unlocking Upside
- MorphoSys ADRs gain after definitive merger agreement with Novartis disclosed
- MorphoSys drops amid speculation Novartis could walk from deal (update)